首页> 外国专利> New enoic acid amide compounds having inhibitory activity against acyl-CoA:cholesterol acyltransferase, process of preparation thereof and composition comprising the same

New enoic acid amide compounds having inhibitory activity against acyl-CoA:cholesterol acyltransferase, process of preparation thereof and composition comprising the same

机译:对酰基辅酶A:胆固醇酰基转移酶具有抑制活性的新烯酰胺化合物,其制备方法和包含该化合物的组合物

摘要

The invention acyl Koei: novel enoic acid amide compound cholesterol transition having enzyme inhibitory activity, relates to their preparation and compositions containing them, wherein enoic acid amide-based compound is Mai Larsen 2 (Mylacen 2) or Mai characterized in that Larsen 3 (Mylacen 3). ; Enoic acid amide compound miter Larsen 2 or Mai Larsen 3 of the present invention are acyl-Koei: Because cholesterol transition effectively inhibit the activity of the enzyme, acyl-Koei: hyperlipidemia cholesterol transition associated with the enzyme, coronary heart disease, arteriosclerosis It can be useful in the prevention and treatment of heart and circulatory diseases such as atherosclerosis and myocardial infarction.
机译:本发明的酰基Koei:具有酶抑制活性的新型烯酸酰胺化合物胆固醇转变,涉及它们的制备和包含它们的组合物,其中基于烯酰胺的化合物是Mai Larsen 2(Mylacen 2)或Mai特征在于Larsen 3(Mylacen)。 3)。 ;本发明的烯酸酰胺化合物的斜接Larsen 2或Mai Larsen 3是酰基-Koei:由于胆固醇的转变有效抑制了该酶的活性,酰基-Koei:高脂血症与该酶有关的胆固醇的转变,冠心病,动脉硬化它可以可用于预防和治疗心脏和循环系统疾病,例如动脉粥样硬化和心肌梗塞。

著录项

  • 公开/公告号KR100607585B1

    专利类型

  • 公开/公告日2006-08-02

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20030090408

  • 发明设计人 박호용;서명철;정태숙;박두상;

    申请日2003-12-11

  • 分类号C07C233/09;

  • 国家 KR

  • 入库时间 2022-08-21 21:23:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号